Reaction

Cryptorchism reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,108 reports · 29 co-occurring drugs

As of the last recalculation, Cryptorchism appears in 1,108 FAERS reports alongside 29 co-occurring drug terms. The strongest observed disproportionality signal is ZIDOVUDINE (PRR 72.0).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Zidovudine4972.072.2
Valproate Sodium5350.550.7
Lopinavir And Ritonavir2941.241.3
Valproic Acid4729.229.3
Levetiracetam In Sodium Chloride9525.125.1
Levetiracetam Oral9525.125.1
Levetiracetam Injection9525.125.1
Clobazam3023.723.7
Tenofovir Disoproxil Fumarate Tablets919.719.8
Oseltamivir819.019.0
Oxcarbazepine3118.418.4
Levetiracetam11217.417.4
Lamivudine Oral2115.915.9
Progesterone1915.915.9
Misoprostol815.515.5
Lamivudine2515.515.5
Phenytoin1715.515.5
Tenofovir Disoproxil Fumarate2615.115.1
Lacosamide2915.015.0
Atazanavir1013.213.2
Norepinephrine712.412.4
Raltegravir1011.511.5
Miconazole Nitrate510.810.8
Norepinephrine Bitartrate810.510.5
Ritonavir1610.410.4
Emtricitabine And Tenofovir Disoproxil Fumarate208.48.4
Pseudoephedrine Hydrochloride47.37.3
Pseudoephedrine Hcl46.86.8
Somatropin164.14.1

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.